Patient information leaflets about cancer trials are too complicated, finds studyBMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2356 (Published 27 March 2012) Cite this as: BMJ 2012;344:e2356
- Susan Mayor
People approached to take part in cancer trials find patient information leaflets about the trials too long and difficult to understand, warns a study, which is informing new guidance on consent procedures.
Researchers at the University of Leicester traced the development and use of patient information leaflets for 13 cancer trials being carried out at a large teaching hospital, although all were multicentre trials. The trials covered a variety of treatments for a range of cancers.
They reviewed leaflets’ content from its initial development by researchers leading the trials and through their review and approval by research ethics committees. Finally, they interviewed 26 adult patients who …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial